STAGE IIIB BREAST CANCER
Clinical trials for STAGE IIIB BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIB BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IIIB BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo offers hope for frail elderly with breast cancer
Disease control CompletedThis study tested a two-drug combination (fulvestrant and palbociclib) to control breast cancer in patients aged 70 and older who could not undergo surgery due to frailty or who refused it. The goal was to see if this non-surgical approach could keep the cancer from growing for a…
Matched conditions: STAGE IIIB BREAST CANCER
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope for Tough-to-Treat breast cancer: Two-Drug combo tested
Disease control CompletedThis study tested whether adding the hormone therapy fulvestrant to a new drug called alisertib works better than alisertib alone for women with advanced breast cancer that has spread and stopped responding to standard hormone treatments. It involved 96 postmenopausal women. Rese…
Matched conditions: STAGE IIIB BREAST CANCER
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC
-
Can fish oil pills fight breast cancer? early trial seeks answers
Knowledge-focused CompletedThis small, early study tested whether short-term use of anti-inflammatory drugs—fish oil capsules or the medication celecoxib—could change the biology of breast cancer diagnosed around pregnancy. Researchers gave one of these treatments to 42 young women for 1-3 weeks before the…
Matched conditions: STAGE IIIB BREAST CANCER
Phase: EARLY_PHASE1 • Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC